Viropharma News
Most Popular Viropharma Story
Wyeth stumbles badly trying to develop new drugs
The analysts have been picking over Wyeth's carcass over the past few days as they assess a string of woeful developments that have left the company stripped of three of its leading drug candidates.... Read more...
Latest Headlines
- August 27, 2009
- February 13, 2009
- February 10, 2009
- October 13, 2008
- July 15, 2008
- April 17, 2008
- August 13, 2007
- August 10, 2007
- August 8, 2007
- November 7, 2006
- August 13, 2006
- January 24, 2006
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
